Novel therapies for severe asthma in children and adults

The heterogeneous nature of asthma requires personalised treatments. Monoclonal antibody treatments showed good efficacy, and should be considered when symptoms are poorly controlled despite good inhaler technique, compliance and controlled comorbidities. http://ow.ly/UWpg30hImQh

Detalles Bibliográficos
Autores principales: Delimpoura, Vasiliki, Bostantzoglou, Clementine, Liu, Norrice, Nenna, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831346/
https://www.ncbi.nlm.nih.gov/pubmed/29515670
http://dx.doi.org/10.1183/20734735.018917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831346/
https://www.ncbi.nlm.nih.gov/pubmed/29515670
http://dx.doi.org/10.1183/20734735.018917

Ejemplares similares